Educational information, not medical advice — ask your doctor or midwife.
Saireito is a classical Kampo (Japanese herbal medicine) formula made up of twelve individual herbs. It is the combination of two well-known Kampo prescriptions: Sho-saiko-to (a liver and immune-modulating formula) and Gorei-san (a water-metabolism formula). This dual action makes it uniquely suited to conditions involving both inflammation and abnormal fluid handling in the body.
Saireito works through several overlapping pathways — it helps calm overactive immune responses, reduce protein loss through the kidneys, and regulate how the body distributes and eliminates fluid. The Bupleurum-based herbs are thought to dampen inflammation, while the Alisma and Polyporus components act like gentle natural diuretics, helping the kidneys manage fluid more efficiently. Together, the formula also appears to support the adrenal system, which is important for patients taking corticosteroids.
In Japan, Saireito is overwhelmingly prescribed as standardized granules (most commonly Tsumura brand, extract granule TJ-114) that dissolve in warm water. This is the form used in virtually all clinical research. Traditional decoction (boiling raw herbs) is less common today. Tablet forms exist but are less widely studied.
Saireito's roots trace back to classical Chinese medicine texts, where the parent formulas Xiao Chai Hu Tang and Wu Ling San were described over 1,800 years ago in the Shang Han Lun (Treatise on Cold Damage Disorders) by Zhang Zhongjing. Japanese Kampo physicians later combined these into Saireito (Chai Ling Tang in Chinese) to address conditions involving both inflammatory heat and fluid stagnation. In modern Japan, Saireito is a government-approved prescription drug covered by national health insurance, reflecting its established role in clinical nephrology and hepatology.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.